These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 35872049)
1. Theacrine ameliorates experimental liver fibrosis in rats by lowering cholesterol storage via activation of the Sirtuin 3-farnesoid X receptor signaling pathway. Lv XT; Wang RH; Liu XT; Ye YJ; Liu XY; Qiao JD; Wang GE Chem Biol Interact; 2022 Sep; 364():110051. PubMed ID: 35872049 [TBL] [Abstract][Full Text] [Related]
2. Theacrine attenuates myocardial fibrosis after myocardial infarction via the SIRT3/β-catenin/PPARγ pathway in estrogen-deficient mice. Song LL; Zhang Y; Zhang XR; Song YN; Dai HZ Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5477-5486. PubMed ID: 31298401 [TBL] [Abstract][Full Text] [Related]
3. Theacrine protects against nonalcoholic fatty liver disease by regulating acylcarnitine metabolism. Wang GE; Li YF; Zhai YJ; Gong L; Tian JY; Hong M; Yao N; Wu YP; Kurihara H; He RR Metabolism; 2018 Aug; 85():227-239. PubMed ID: 29727630 [TBL] [Abstract][Full Text] [Related]
4. Lactoferrin promotes bile acid metabolism and reduces hepatic cholesterol deposition by inhibiting the farnesoid X receptor (FXR)-mediated enterohepatic axis. Ling CJ; Xu JY; Li YH; Tong X; Yang HH; Yang J; Yuan LX; Qin LQ Food Funct; 2019 Nov; 10(11):7299-7307. PubMed ID: 31626262 [TBL] [Abstract][Full Text] [Related]
5. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581 [TBL] [Abstract][Full Text] [Related]
6. Phillygenin Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis: Suppression of Inflammation and Wnt/β-Catenin Signaling Pathway. Wang C; Liu Y; Gong L; Xue X; Fu K; Ma C; Li Y Inflammation; 2023 Aug; 46(4):1543-1560. PubMed ID: 37219693 [TBL] [Abstract][Full Text] [Related]
7. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference. Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431 [TBL] [Abstract][Full Text] [Related]
8. Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis. Liu H; Pathak P; Boehme S; Chiang JL J Lipid Res; 2016 Oct; 57(10):1831-1844. PubMed ID: 27534992 [TBL] [Abstract][Full Text] [Related]
9. Theacrine enhances autophagy and inhibits inflammation via regulating SIRT3/FOXO3a/Parkin pathway. Li J; Yan W; Yuan H; Ren F Int J Rheum Dis; 2024 Feb; 27(2):e15085. PubMed ID: 38402443 [TBL] [Abstract][Full Text] [Related]
10. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway. Ma JQ; Sun YZ; Ming QL; Tian ZK; Yang HX; Liu CM Int Immunopharmacol; 2019 Dec; 77():105984. PubMed ID: 31677501 [TBL] [Abstract][Full Text] [Related]
11. Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation. Twu YC; Lee TS; Lin YL; Hsu SM; Wang YH; Liao CY; Wang CK; Liang YC; Liao YJ Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420058 [TBL] [Abstract][Full Text] [Related]
12. Theacrine, a purine alkaloid from kucha, protects against Parkinson's disease through SIRT3 activation. Duan WJ; Liang L; Pan MH; Lu DH; Wang TM; Li SB; Zhong HB; Yang XJ; Cheng Y; Liu B; Li WX; Kurihara H; Bi W; Li YF; He RR Phytomedicine; 2020 Oct; 77():153281. PubMed ID: 32707370 [TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175 [TBL] [Abstract][Full Text] [Related]
14. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction. Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916 [TBL] [Abstract][Full Text] [Related]
15. Yu Gan Long Ameliorates Hepatic Fibrosis by Inhibiting PI3K/AKT, Ras/ERK and JAK1/STAT3 Signaling Pathways in CCl Li HG; You PT; Xia Y; Cai Y; Tu YJ; Wang MH; Song WC; Quan TM; Ren HY; Liu YW; Dan HX; Xu SQ Curr Med Sci; 2020 Jun; 40(3):539-547. PubMed ID: 32681257 [TBL] [Abstract][Full Text] [Related]
16. Ligustroflavone ameliorates CCl Kang R; Tian W; Cao W; Sun Y; Zhang HN; Feng YD; Li C; Li ZZ; Li XQ Chin J Nat Med; 2021 Mar; 19(3):170-180. PubMed ID: 33781450 [TBL] [Abstract][Full Text] [Related]
17. Theacrine, a purine alkaloid obtained from Camellia assamica var. kucha, attenuates restraint stress-provoked liver damage in mice. Li WX; Li YF; Zhai YJ; Chen WM; Kurihara H; He RR J Agric Food Chem; 2013 Jul; 61(26):6328-35. PubMed ID: 23678853 [TBL] [Abstract][Full Text] [Related]
18. Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1. Zhang C; Liu XQ; Sun HN; Meng XM; Bao YW; Zhang HP; Pan FM; Zhang C Int Immunopharmacol; 2018 Oct; 63():183-190. PubMed ID: 30098497 [TBL] [Abstract][Full Text] [Related]
19. Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activation. Wang X; Fu T; Wang J; Wang C; Liu K; Wu J; Sun H; Ma X; Sun P; Meng Q Int Immunopharmacol; 2019 Oct; 75():105833. PubMed ID: 31450152 [TBL] [Abstract][Full Text] [Related]
20. Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats. He J; Bai K; Hong B; Zhang F; Zheng S Int Immunopharmacol; 2017 Dec; 53():56-62. PubMed ID: 29035816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]